Lakewood-Amedex Biotherapeutics Inc. (LABT) Live Share Price, Invest From India

Lakewood-Amedex Biotherapeutics Inc. Stock Performance

as on July 28, 2026 at 6:59 am IST

Day's Low
Day's High
$2.35
Day's Price Range
$2.83
$2.43
3.29%
Downside
16.46%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$2.43
100.00%
Downside
-100.00%
Upside

Lakewood-Amedex Biotherapeutics Inc. share price movements today

Previous Close: $2.64
Open: $2.43
Volume: 636.6K
Day's Low - High: $2.35 - $2.83

Lakewood-Amedex Biotherapeutics Inc. Historical Returns

1 Month Return: -24.79 %
3 Month Return: -93.21 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Lakewood-Amedex Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check Lakewood-Amedex Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.6M

EPS (TTM)

-2.52

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Lakewood-Amedex Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lakewood-Amedex Biotherapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lakewood-Amedex Biotherapeutics Inc.	NA	$4.6M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.2B	539.29%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$121.2B	136.04%	28.33	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$68.8B	11.87%	16.02	29.65%	0.5499999999999999%

Indian Investors' Interest in Lakewood-Amedex Biotherapeutics Inc. Stock

Investment in Lakewood-Amedex Biotherapeutics Inc. Shares on INDmoney has grown by 958.33% in the last 30 days, indicating increased investment activity.

Time period: June 28, 2026 to July 28, 2026

Change:958.33% versus previous 30 day period

Search interest for Lakewood-Amedex Biotherapeutics Inc. Stock has increased by 1038% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 28, 2026 to July 28, 2026

Change:1038% versus previous 30 day period

Lakewood-Amedex Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Income	0	0	-1	0	0
EBITDA	-	-	-	-	0
Interest Expense	-	0	0	0	0
Depreciation	0	0	0	0	0
Income Before Tax	0	0	-1	0	0
Income Tax Expense	-	-	-	-	-
Net Income	0	0	-1	0	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Lakewood-Amedex Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-8	-4	-3
EBITDA	-	-	-
Interest Expense	0	0	0
Depreciation	0	0	0
Income Before Tax	-8	-4	-3
Income Tax Expense	-	-	-
Net Income	-8	-4	-3
Net Profit Margin	0.00%	0.00%	0.00%

Lakewood-Amedex Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	-1	0	0
Operating Cash Flow	0	-	0	0
Investing Cash Flow	-	-	-	-
Financing Cash Flow	0	-	-	0
Change in Cash	0	-	0	0

Lakewood-Amedex Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-4	-3
Operating Cash Flow	-5	-1
Investing Cash Flow	-	-
Financing Cash Flow	0	1
Change in Cash	-1	0

Insights on Lakewood-Amedex Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, LABT stock has moved up by 36.8%

About Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Organisation	Lakewood-Amedex Biotherapeutics Inc.
Headquarters	8031 Cooper Creek Blvd., University Park, FL, United States, 34201
Industry	Biotechnology
CEO	Dr. Kelvin Cooper Ph.D.
E-voting on shares	Click here to vote

Key Management of Lakewood-Amedex Biotherapeutics Inc.

Name	Title
Mr. Peter F. Ceccacci	CFO & VP of Administration
Dr. Thomas Balzer M.D., Ph.D.	Chief Medical Officer & SVP of Clinical Development
Ms. Tara Endress	Project Manager & Accounting Manager
Daniel Kontoh-Boateng	Investor Relations
Dr. Kelvin Cooper Ph.D.	CEO, SVP of Research & Development and Director

FAQs

What is Lakewood-Amedex Biotherapeutics Inc. share price today?

Lakewood-Amedex Biotherapeutics Inc. share price today is $2.43 as on July 28, 2026 at 1:29 am IST at the close of the market. Lakewood-Amedex Biotherapeutics Inc. share today touched a day high of $2.83 and a low of $2.35.

What is the 52 week high and 52 week low for Lakewood-Amedex Biotherapeutics Inc. share?

Lakewood-Amedex Biotherapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Lakewood-Amedex Biotherapeutics Inc. stock price today i.e. July 28, 2026 at 1:29 am IST is closed at $2.43,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Lakewood-Amedex Biotherapeutics Inc.'s market capitalisation today?

Lakewood-Amedex Biotherapeutics Inc. market capitalisation is $0.00T as on July 28, 2026 at 1:29 am IST.

How to invest in Lakewood-Amedex Biotherapeutics Inc. Stock (LABT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lakewood-Amedex Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lakewood-Amedex Biotherapeutics Inc. Shares that will get you 0.6173 shares as per Lakewood-Amedex Biotherapeutics Inc. share price of $2.43 per share as on July 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lakewood-Amedex Biotherapeutics Inc. Stock (LABT) from India?

Indian investors can start investing in Lakewood-Amedex Biotherapeutics Inc. (LABT) shares with as little as ₹95.9 or $1 (as of July 28, 2026 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.00 in Lakewood-Amedex Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 28, 2026 at 4:37 am IST). Based on Lakewood-Amedex Biotherapeutics Inc. share’s latest price of $2.43 as on July 28, 2026 at 1:29 am IST, you will get 4.1152 shares of Lakewood-Amedex Biotherapeutics Inc.. Learn more about fractional shares .